Skip to main content

December 1, 2022

The Feasibility of Goal Attainment Scaling in SCN2A-associated Neurodevelopmental Disorders

Results suggest that Goal Attainment Scaling may offer a feasible, family-centered approach to capturing the patient experience and meaningful changes

At the American Epilepsy Society (AES) 2022, we presented our findings from The Inchstone Project, which focuses on accelerating outcome measures for individuals with severe Developmental Epileptic Encephalopathies (DEE), determining the feasibility of using goal attainment scaling (GAS) to capture clinically meaningful change in the SNC2A- DEE population.

Contact Us

Local with a global impact

Based in Nova Scotia, our culture reflects an East Coast Canadian ethos rooted in hard work and collegiality.

With over a decade of experience partnering with multinational sponsors on cutting-edge patient-centric research, the impact of our work is global.

Follow us for more: